Delisting riskEarnings are out
Immutep (ADR) (IMMP)
Develops LAG-3 immunotherapies for cancer and autoimmune disease.
$0.3717
Pre-market−0.01 (−2.93%)
At close$0.3829(+3.15%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions28 holders · as of Mar 31, 2026 | 1.77% | 2.61M ADS | |
| Insiders8 holders · as of Apr 16, 2026 | 4.43% | 6.53M ADS | |
| Otherremainder | 93.80% | 138.24M ADS |
147.37M ADS (1 ADS = 6 ordinary shares) as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
The share count is from the company's Jun 2022 annual report; nothing newer is on file here.
Institutions13F, as of Mar 31, 2026
28 holders · 2.61M shares · 10 new positions · 14 increased · 9 reduced · 9 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 810.9K | 0.55% | −12.6K | May 13, 2026 |
| UBS Group AG | 748.8K | 0.51% | +678.4K | May 5, 2026 |
| Meridian Wealth Management, LLC | 449.6K | 0.31% | −4.9K | May 6, 2026 |
| Two Sigma Investments, LP | 124.8K | 0.08% | +30.2K | May 15, 2026 |
| Citadel Advisors LLC | 78.2K | 0.05% | +78.2K | May 15, 2026 |
| XTX Topco Ltd | 73.8K | 0.05% | +73.8K | May 15, 2026 |
| Two Sigma Securities, LLC | 53.6K | 0.04% | +53.6Knew | May 15, 2026 |
| Virtu Financial LLC | 41.4K | 0.03% | +41.4K | May 14, 2026 |
Ownership statements13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.